DAP.F

Danaher Corporation | Cotação de Ações

Última atualização23/12/2024, 12:45:22

Preço€ 219,55

Variação (dia)€ 0,05 (0.02%)▲

Min. 52 Semanas€ 204,70

Máx. 52 Semanas€ 259,20

Capitalização de mercado--

Endereço: 2200 Pennsylvania Avenue, North West, Washington, DC, 20037-1701

Telefone: 202 828 0850

Funcionários: 61.000

DANAHER CORP. RDAP.F

€ 219,55

+ 0,050,023%

23/12/2024 12:45:22

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atual€ 219,55

Valor de mercado--

Abertura€ 222,60

Preço máximo€ 220,25

Preço mínimo€ 218,60

Volume€ 1,2 mil

Fechamento anterior€ 219,50

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Ações relacionadas

Stryker Corporation

SYK.F ▲2.20% | € 350,70

McDonald's Corporation

MDO.F ▼3.00% | € 278,50

NextEra Energy, Inc.

FP3.F ▲0.59% | € 69,11

Thermo Fisher Scientific Inc.

TN8.F ▼2.30% | € 501,20

The Procter & Gamble Company

PRG.F ▼1.88% | € 160,32

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Encontre respostas para suas dúvidas sobre investimentos em nossa seção de Perguntas Frequentes (FAQ)

Acesse a seção de Perguntas Frequentes da brapi para esclarecer dúvidas sobre investimentos. Nossa FAQ fornece informações concisas, abordando tópicos relevantes para investidores, contribuindo para uma compreensão mais clara do mercado financeiro.